JPMorgan Chase & Co. Boosts Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

JPMorgan Chase & Co. lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 602.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,792,579 shares of the exchange traded fund’s stock after buying an additional 5,825,292 shares during the period. JPMorgan Chase & Co. owned approximately 12.43% of SPDR S&P Biotech ETF worth $921,413,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Brown Advisory Inc. boosted its position in SPDR S&P Biotech ETF by 481.7% in the fourth quarter. Brown Advisory Inc. now owns 55,321 shares of the exchange traded fund’s stock worth $7,788,000 after purchasing an additional 45,810 shares during the last quarter. FundX Investment Group LLC increased its holdings in SPDR S&P Biotech ETF by 10.2% during the first quarter. FundX Investment Group LLC now owns 17,598 shares of the exchange traded fund’s stock worth $2,387,000 after buying an additional 1,634 shares during the last quarter. Smart Portfolios LLC bought a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $2,565,000. Conservest Capital Advisors Inc. boosted its stake in SPDR S&P Biotech ETF by 32.9% in the first quarter. Conservest Capital Advisors Inc. now owns 10,923 shares of the exchange traded fund’s stock valued at $1,482,000 after acquiring an additional 2,704 shares during the last quarter. Finally, Davis R M Inc. grew its position in shares of SPDR S&P Biotech ETF by 9.8% during the 1st quarter. Davis R M Inc. now owns 108,372 shares of the exchange traded fund’s stock valued at $14,701,000 after acquiring an additional 9,676 shares during the period.

Shares of NYSEARCA:XBI traded down $0.72 during mid-day trading on Friday, reaching $135.37. The company had a trading volume of 152,396 shares, compared to its average volume of 6,808,105. SPDR S&P Biotech ETF has a one year low of $97.15 and a one year high of $174.79. The company has a 50-day simple moving average of $130.31.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading: What is the Fibonacci sequence?

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.